Please be sure to review ALL instructions below that apply to your specimen(s).

Specimens Submitted from North America

Non-Prenatal Specimens for Diagnostic Testing: Please send ONE of the following types of specimens:
  • Whole blood: purple-top (EDTA) tube, minimum of 3 ml.  Whole blood should be stored at 4°C until shipped.

  • Genomic DNA*:  minimum of 3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

  • Fibroblasts: minimum of 2 confluent T-25 flasks. Please fill all flasks to capacity with cell culture media.

  • Saliva:  Saliva for CNV (highly recommend whole blood for CNV). Only samples collected in Oragene DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children are accepted (www.dnagenotek.com).

Non-Prenatal Specimens for Carrier Screening: Please send ONE of the following types of specimens:

  • Whole blood: purple-top (EDTA) tube, minimum of 3 ml.  Whole blood should be stored at 4°C until shipped.

  • Genomic DNA*:  minimum of 3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Prenatal Specimens for Diagnostic Testing: Please send ONE of the following types of specimens:

  • Cultured cells: minimum of 2 confluent T-25 flasks derived from amnio or CVS samples.  Please fill all flasks to capacity with cell culture media.

  • Genomic DNA*:  minimum of 3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

HNL Genomics (CTGT) highly recommends including a maternal sample for maternal cell contamination studies with all prenatal tests. Maternal sample requirements are as listed above in the Non-Prenatal Specimens section.

Specimens from Outside of North America

  • Please send genomic DNA*:  a minimum of 3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

HNL Genomics (CTGT) does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada or Mexico.

Technical Guidelines

If any of the guidelines for these processes are not met, the specimen may be rejected, or the test may be placed on hold. HNL Genomics (CTGT) will contact the client for resolution.
The following list represents some possible causes for specimen rejection:

  • Improperly labeled specimen (minimum of two patient identifiers).

  • Inappropriate specimen type (genomic DNA isolated from FFPE specimen is not accepted).

  • Incomplete or incorrect test request form (i.e. no test marked).

  • Insufficient volume for analysis.

  • Specimen has leaked in transit.

  • Specimen without a test order.

  • All sample types should be shipped at ambient temperature via an overnight courier.

  • Please review the instructions on the Shipping page to ensure that your shipment is received in good condition by HNL Genomics (CTGT) .

  • Please note that genomic DNA is accepted only from CLIA-certified laboratories or laboratories meeting equivalent requirements.

  • Please note that genomic DNA isolated from FFPE specimens is not accepted.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.

News

October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More